Vergent Bioscience

Vergent Bioscience

A clinical-stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic-assisted surgery by significantly improving the visibility of tumors.

Launch date
Employees
Market cap
-
Enterprise valuation
CAD117—176m (Dealroom.co estimates Oct 2022.)
Minneapolis Minnesota (HQ)
Authorizing premium user...